1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    














































































































    MRI Grading versus Histology: Predicting Survival of World Health Organization Grade II–IV Astrocytomas | American Journal of Neuroradiology  
    

















    





























    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      

  
      
MRI Grading versus Histology: Predicting Survival of World Health Organization Grade II–IV Astrocytomas
  
    	
A. Lasocki, A. Tsui, M.A. Tacey, K.J. Drummond, K.M. Field and F. Gaillard

  
    	
American Journal of Neuroradiology January 2015,  36 (1) 77-83; DOI: https://doi.org/10.3174/ajnr.A4077 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Louis  DN
    . ed. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: International Agency for Research on Cancer; 2007
  2. 2.↵


    1. 

    2. Ohgaki  H, 
    3. Kleihues  P
    . The definition of primary and secondary glioblastoma. Clinical Cancer Research 2013;19:764–72
    Abstract/FREE Full Text
  3. 3.↵


    1. 

    2. Chandrasoma  PT, 
    3. Smith  MM, 
    4. Apuzzo  ML
    . Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen Neurosurgery 1989;24:160–65
    CrossRefPubMedWeb of Science
  4. 4.↵


    1. 

    2. Glantz  MJ, 
    3. Burger  PC, 
    4. Herndon  JE, et al
    . Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741–44
    CrossRef
  5. 5.↵


    1. 

    2. Jackson  RJ, 
    3. Fuller  GN, 
    4. Abi-Said  D, et al
    . Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol 2001;3:193–200
    Abstract/FREE Full Text
  6. 6.↵


    1. 

    2. Coons  SW, 
    3. Johnson  PC, 
    4. Scheithauer  BW, et al
    . Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997;79:1381–93
    CrossRefPubMedWeb of Science
  7. 7.↵


    1. 

    2. Mittler  MA, 
    3. Walters  BC, 
    4. Stopa  EG
    . Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg 1996;85:1091–94
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. 

    2. Prayson  RA, 
    3. Agamanolis  DP, 
    4. Cohen  ML, et al
    . Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci 2000;175:33–39
    CrossRefPubMed
  9. 9.↵


    1. 

    2. Dean  BL, 
    3. Drayer  BP, 
    4. Bird  CR, et al
    . Gliomas: classification with MR imaging. Radiology 1990;174:411–15
    CrossRefPubMedWeb of Science
  10. 10.↵


    1. 

    2. Knopp  EA, 
    3. Cha  S, 
    4. Johnson  G, et al
    . Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98
    CrossRefPubMedWeb of Science
  11. 11.↵


    1. 

    2. Law  M, 
    3. Yang  S, 
    4. Wang  H, et al
    . Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98
    Abstract/FREE Full Text
  12. 12.↵


    1. 

    2. Möller-Hartmann  W, 
    3. Herminghaus  S, 
    4. Krings  T, et al
    . Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371–81
    CrossRefPubMedWeb of Science
  13. 13.↵


    1. 

    2. Arvinda  HR, 
    3. Kesavadas  C, 
    4. Sarma  PS, et al
    . Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol 2009;94:87–96
    CrossRefPubMed
  14. 14.↵


    1. 

    2. Kim  HS, 
    3. Kim  SY
    . A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas. AJNR Am J Neuroradiol 2007;28:1693–99
    Abstract/FREE Full Text
  15. 15.↵


    1. 

    2. Brown  PD
    . Low-grade gliomas: the debate continues. Curr Oncol Rep 2006;8:71–77
    CrossRefPubMed
  16. 16.↵


    1. 

    2. DeAngelis  LM
    . Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. J Clin Oncol 2009;27:5861–62
    FREE Full Text
  17. 17.↵


    1. 

    2. Stupp  R, 
    3. Mason  WP, 
    4. van den Bent  MJ, et al
    . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. 

    2. Field  KM, 
    3. Drummond  KJ, 
    4. Yilmaz  M, et al
    . Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset. J Clin Neurosci 2013;20:783–89
    CrossRefPubMed
  19. 19.↵


    1. 

    2. Pope  WB, 
    3. Sayre  J, 
    4. Perlina  A, et al
    . MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 2005;26:2466–74
    Abstract/FREE Full Text
  20. 20.↵


    1. 

    2. Chishty  IA, 
    3. Rafique  MZ, 
    4. Hussain  M, et al
    . MRI characterization and histopathological correlation of primary intra-axial brain glioma. Journal of the Liaquat University of Medical and Health Sciences 2010;9:64–69
  21. 21.↵


    1. 

    2. Zonari  P, 
    3. Baraldi  P, 
    4. Crisi  G
    . Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 2007;49:795–803
    CrossRefPubMedWeb of Science
  22. 22.↵


    1. 

    2. Chawla  S, 
    3. Wang  S, 
    4. Wolf  RL, et al
    . Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas. AJNR Am J Neuroradiol 2007;28:1683–89
    Abstract/FREE Full Text
  23. 23.↵


    1. 

    2. Bisdas  S, 
    3. Kirkpatrick  M, 
    4. Giglio  P, et al
    . Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? AJNR Am J Neuroradiol 2009;30:681–88
    Abstract/FREE Full Text
  24. 24.↵


    1. 

    2. Meyerand  ME, 
    3. Pipas  JM, 
    4. Mamourian  A, et al
    . Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol 1999;20:117–23
    Abstract/FREE Full Text
  25. 25.↵


    1. 

    2. Pinker  K, 
    3. Noebauer-Huhmann  IM, 
    4. Stavrou  I, et al
    . High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR Am J Neuroradiol 2007;28:1280–86
    Abstract/FREE Full Text
  26. 26.↵


    1. 

    2. Asari  S, 
    3. Makabe  T, 
    4. Katayama  S, et al
    . Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology 1994;36:308–10
    CrossRefPubMed
  27. 27.↵


    1. 

    2. Bulakbasi  N, 
    3. Kocaoglu  M, 
    4. Örs  F, et al
    . Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003;24:225–33
    Abstract/FREE Full Text
  28. 28.↵


    1. 

    2. Bulakbasi  N, 
    3. Kocaoglu  M, 
    4. Farzaliyev  A, et al
    . Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 2005;26:2187–99
    Abstract/FREE Full Text
  29. 29.↵


    1. 

    2. Krouwer  HG, 
    3. Davis  RL, 
    4. Silver  P, et al
    . Gemistocytic astrocytomas: a reappraisal. J Neurosurg 1991;74:399–406
    CrossRefPubMedWeb of Science
  30. 30.↵


    1. 

    2. Avninder  S, 
    3. Sharma  M, 
    4. Deb  P, et al
    . Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations: a study of 32 cases. J Neurooncology 2006;78:123–27
    CrossRefPubMed
  31. 31.↵


    1. 

    2. Thomas  La, 
    3. Di Stefano  AL, 
    4. Ducray  F
    . Predictive biomarkers in adult gliomas: the present and the future. Curr Opin Oncol 2013;25:689–94
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
MRI Grading versus Histology: Predicting Survival of World Health Organization Grade II–IV Astrocytomas
  
    	
A. Lasocki, A. Tsui, M.A. Tacey, K.J. Drummond, K.M. Field, F. Gaillard

  
    	
American Journal of Neuroradiology Jan 2015, 36 (1) 77-83; DOI: 10.3174/ajnr.A4077 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement